$4.440
-0.098 (-2.20%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de GTBP por análisis de gráficos similares
Alphio's GTBP stock price prediction model matches the current GT Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.43 (-0.19%). The 1-week path is $4.41 (-0.67%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de GT Biopharma Inc?
GT Biopharma Inc is not a good buy right now due to a significant net loss of $28.4 million for FY2025 and a current RSI of 23.39, indicating oversold conditions but also potential ongoing weakness. The stock has dropped 78.26% year-to-date, reflecting severe market challenges and investor sentiment issues.
GTBP cerró en $4.44 el Friday, tras bajar -2.20%
GT Biopharma Inc (GTBP) last closed at $4.4400001, losing -2.20%. These facts feed the 1-day and 1-week GTBP price prediction above.
Factores de la previsión
Los factores de la previsión de GT Biopharma Inc (GTBP) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de GTBP, ordenadas por similitud.
Análisis de estacionalidad de GTBP
Historically the probability of a positive November return for GTBP is 0.00%. June offers the highest probability of a positive month at 16.67%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de GTBP
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.97 | $2.17 | $2.56 | -51.03% |
| Dec 2026 | $2.03 | $2.26 | $2.28 | -49.05% |
En 2026, se proyecta que GT Biopharma Inc (GTBP) oscile entre $1.97 y $2.56.
Previsión mensual de GT Biopharma Inc para 2026
En Nov de 2026, se proyecta que GT Biopharma Inc promedie $2.17, con un mínimo de $1.97 y un máximo de $2.56.
En Dec de 2026, se proyecta que GT Biopharma Inc promedie $2.26, con un mínimo de $2.03 y un máximo de $2.28.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.